Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 85
Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 Appendixes
OCR for page 86
Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 This page intentionally left blank.
OCR for page 87
Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 Appendix A Biographies of Speakers CLAUDIA R. BAQUET, M.D., M.P.H., is associate dean for policy and planning and associate professor of epidemiology and preventive medicine at the University of Maryland School of Medicine. She also serves as director of the Maryland Area Health Education Center, director of the Center for Health Policy/Health Services Research, director of the Cancer Disparities and Intervention Research Program, principal investigator of the Maryland Special Populations Cancer Research Network, and director of the University of Maryland Statewide Health Network. Throughout her government and academic career, Dr. Baquet has been a champion of issues related to health disparities and the underserved and is considered a leading national expert on cancer in minority and low-income populations. LOIS COLBURN is assistant vice president in the Division of Community and Minority Programs of the Association of American Medical Colleges (AAMC). She is currently deputy director of the Robert Wood Johnson Foundation–Kellogg Health Professions Partnership Initiative, which helps to develop partnerships among academic medical centers, undergraduate institutions, and secondary schools as a means of increasing the number of academically competitive minority students in the health professions pipeline. She is also the editor of Minorities in Medical Education: Facts and Figures, an annual publication detailing the enrollment and graduation trends of minority students in U.S. medical schools. Ms. Colburn is
OCR for page 88
Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 involved as well in the development of minority faculty initiatives, most notably the AAMC Health Services Research Institute. WILLIAM CROWLEY JR., M.D., is director of clinical research and chief of the Reproductive Endocrine Unit at Massachusetts General Hospital, director of the National Center for Infertility Research, and professor of medicine at Harvard University. Dr. Crowley is the founder of the Academic Health Center Clinical Research Forum and is a member of the board of directors and executive committee of the Federation of American Societies for Experimental Biology. His research interests are neuroendocrine control and reproduction and growth, physiology of puberty, and physiology of gonadotropin secretion. SHERINE E. GABRIEL, M.D., M.Sc., is professor of epidemiology and medicine at Mayo Medical School and is currently chair of the Department of Health Sciences Research at Mayo Clinic, Rochester, Minnesota. She holds dual appointments as Mayo Clinic consultant in the Departments of Internal Medicine/Rheumatology and Health Sciences Research/Epidemiology. Her research has been widely recognized, nationally and internationally. Dr. Gabriel’s commitment to clinical research also extends to clinical research training. In 1999 she led a team of clinical investigators from Mayo who prepared and submitted a proposal for a new clinical research training program at Mayo Clinic in response to the new K30 initiative. This grant was awarded and the Mayo application received a score of 133, establishing Mayo Clinic as one of the top medical centers receiving this institutional award. WILLIAM R. GALEY, Ph.D., is director of the Graduate Science Education Program at the Howard Hughes Medical Institute (HHMI). Before joining HHMI, Dr. Galey was at the University of New Mexico School of Medicine, where he served as interim associate dean for research, assistant dean for graduate studies, and director of the Biomedical Sciences Graduate Program, a training program for Ph.D. and M.D.-Ph.D. candidates. E. NIGEL HARRIS, M.Phil., M.D., D.M., is dean and senior vice president for academic affairs of the Morehouse School of Medicine, a position he has held since January 1996. Dr. Harris’s research career has been largely devoted to the study of antiphospholipid antibodies. He helped devise the
OCR for page 89
Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 anticardiolipin test, and later introduced calibrators for the anticardiolipin assay and units for measurement of anticardiolipin antibody levels. In 1987 Dr. Harris established a new laboratory with Dr. Silvia Pierangeli. WILLIAM N. KELLEY, M.D., former chief executive officer and dean of the University of Pennsylvania Health System and School of Medicine, is professor of medicine and of biochemistry and biophysics at the University of Pennsylvania. He also currently serves as a director of Merck & Co., Beckman Coulter Inc., GenVec Inc., and Advanced Bio-Surfaces Inc., and as a trustee of Emory University and the Woodruff Health Sciences Center of Emory University. Dr. Kelley is a member of the Institute of Medicine. EVAN D. KHARASCH, M.D., Ph.D., is the assistant dean for clinical research at the University of Washington School of Medicine. He is also professor and director of research, Department of Anesthesiology, and adjunct professor of medicinal chemistry at the University of Washington, Seattle. His research areas include clinical pharmacology of anesthetic and analgesic drugs; laboratory, clinical, and noninvasive assessment of drug disposition, metabolism, and drug interactions; clinical optimization of analgesic drug use; mechanisms of interindividual variability in opioid disposition and response; and mechanisms of anesthetic toxification and detoxification. Dr. Kharasch is a practicing anesthesiologist. THOMAS J. LAWLEY, M.D., is dean and William P. Timmie Professor of Dermatology at Emory University School of Medicine. He is an internationally known expert in autoimmune skin diseases. Dr. Lawley currently serves on the Administrative Council of the Association of American Medical Colleges. He is president of the Emory Medical Care Foundation (Emory’s physician practice plan at Grady Hospital) and president of the Emory Children’s Center. MARY D. LEVECK, R.N., Ph.D., is the deputy director of the National Institute of Nursing Research (NINR) at the National Institutes of Health (NIH). She also serves as the director of the Division of Extramural Activities. Prior to assuming her current duties, she was a branch chief and extramural program director at NINR beginning in 1990. Previously, she held faculty and administrative positions at the College of Nursing, University of South Carolina, Columbia. At NIH her major initiatives have
OCR for page 90
Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 been in the area of symptom management of acute pain and management of the behavioral symptoms of Alzheimer’s disease patients. Dr. Leveck is currently on the board of governors of the NIH Clinical Center. DIOMEDES LOGOTHETIS, Ph.D., is the dean of the Graduate School of Biological Sciences and acting director of the Medical Scientists Training Program at the Mount Sinai School of Medicine. He has been with the faculty of physiology and biophysics at Mount Sinai School of Medicine since 1993. His research, which is funded by the National Institutes of Health, National Science Foundation, and American Heart Association, is directed toward understanding in molecular terms how the activity of potassium ion channels is controlled by extracellular signals, such as hormones and neurotransmitters. JOHN R. LUMPKIN, M.D., M.P.H., is senior vice president for health care at the Robert Wood Johnson Foundation (RWJF). Prior to joining RWJF, he was the first African American to hold the position of director of the Illinois Department of Public Health (IDPH). Dr. Lumpkin’s career in public health began with his appointment in 1985 as associate director of IDPH’s Office of Health Care Regulations, which oversees the licensing, inspection, and certification of healthcare facilities. SHIRLEY M. MALCOM, Ph.D., is head of the Directorate for Education and Human Resources Programs of the American Association for the Advancement of Science. The directorate includes programs in education, activities for underrepresented groups, and public understanding of science and technology. From 1994 to 1998 Dr. Malcom served on the National Science Board, the policy-making body of the National Science Foundation, and from 1994 to 2001 she served on the President’s Committee of Advisors on Science and Technology. In 2003 Dr. Malcom received the Public Welfare Medal of the National Academy of Sciences, the highest award given by the academy. RICK A. MARTINEZ, M.D., is director of medical affairs for corporate community relations at Johnson & Johnson. Dr. Martinez has been director of CNS Medical Affairs at Janssen Pharmaceutical, associate director of the Janssen Research Foundation, and chief of geriatric psychopharmacology research with the National Institute of Mental Health. He is currently an issue expert for the Ad Council’s Public Issues Committee.
OCR for page 91
Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 ANGELA BARRON McBRIDE, R.N., Ph.D., is currently an Institute of Medicine nurse scholar. She is also dean emerita and distinguished professor at the Indiana University School of Nursing. Dr. McBride’s research interests include the experience of parents, health concerns of women, and functional assessment of the seriously mentally ill. She is a member of the Institute of Medicine. CRAIG McCLAIN, M.D., holds the University Distinguished Chair in Hepatology, serves as vice chair for research in the Department of Internal Medicine, and holds a graduate faculty appointment in pharmacology and toxicology at the University of Louisville. Prior to joining the faculty of the University of Louisville, he served as director of the NIH-funded General Clinical Research Center. Dr. McClain has more than 25 years of continuous federal funding, and his research focus is cytokines and liver disease. NANCY E. REAME, Ph.D., R.N., is the Mary Dickey Lindsay Professor of Nursing and director of the DNSc Program at Columbia University. Previously she held the Rhetaugh G. Dumas Endowed Chair at the University of Michigan School of Nursing. She is an infertility nursing specialist, reproductive physiologist, and women’s health researcher who conducts studies in the reproductive endocrinology of reproduction and menopause, and the bioethical aspects of assisted reproduction. Her current work is testing the theory that menopause starts in the brain, rather than in the ovary, where the gradual loss of eggs leads to a fall in estrogen. Her additional research includes programs looking at reproductive endocrinology, menstrual cycle, menopause, infertility, gender and health, and surrogate pregnancy. She initially studied nursing at Michigan State University and earned her master’s and Ph.D. in maternity nursing and physiology at Wayne State. In 1980 she became a tenured professor at the University of Michigan. Dr. Reame is a member of the Institute of Medicine. E. ALBERT REECE, M.D., Ph.D., M.B.A., is vice chancellor and dean of the College of Medicine at the University of Arkansas for Medical Sciences. Dr. Reece served on the faculty at Yale from 1982 to 1991 and was the Abraham Roth Professor and chair of the Department of Obstetrics, Gynecology, and Reproductive Sciences at the Temple University School of Medicine from 1991 to 2001. In addition, during this period he directed the Division of Maternal-Fetal Medicine and the Center for Fetal Diagnosis. His research focuses on diabetes in pregnancy, birth defects, and prenatal
OCR for page 92
Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 diagnosis. Dr. Reece is a member of the Institute of Medicine and of its Clinical Research Roundtable. FRED SANFILIPPO, M.D., Ph.D., is the senior vice president for health sciences, dean of the College of Medicine and Public Health, and corporate executive officer of the Medical Center at Ohio State University. Dr.Sanfilippo was a member of the Duke University faculty from 1979 through 1992 and served as professor of pathology, surgery, and immunology, director of the Immunogenetics-Transplantation Laboratory, and chief of immunopathology. From 1993 to 2000 he was the Baxley Professor and Chair of Pathology and pathologist in chief at the Johns Hopkins Medical Institutions and served as director of the Johns Hopkins Medical Laboratories and director of research of the Johns Hopkins Comprehensive Transplant Center. S. CLIFFORD SCHOLD JR., M.D., is associate vice chancellor for clinical research at the University of Pittsburgh Schools of the Health Sciences. Dr. Schold was formerly associated with the Duke Clinical Research Institute as director for neurosciences. He has also served as chair of the Department of Neurology at the University of Texas Southwestern Medical Center at Dallas. He is a neurologist with a subspecialty focus on neurooncology. LARRY J. SHAPIRO, M.D., is the Spencer T. and Ann W. Olin Distinguished Professor and executive vice chancellor for medical affairs and dean of the School of Medicine at Washington University in St. Louis. Prior to joining the faculty at Washington University, Dr. Shapiro was the W. H. and Marie Wattis Distinguished Professor and chair of the Department of Pediatrics at the University of California San Francisco (UCSF), and chief of pediatric services at the UCSF Children’s Hospital. Dr. Shapiro’s research interests have included human molecular genetics and inborn errors of metabolism. STEPHEN E. STRAUS, M.D., was appointed the first director of the National Center for Complementary and Alternative Medicine in October 1999. An internationally recognized expert in clinical research and clinical trials, Dr. Straus is also senior investigator in the Laboratory of Clinical Investigation at the National Institute of Allergy and Infectious Diseases (NIAID). He has extensive basic and clinical research experience related to
OCR for page 93
Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 many conditions for which there are alternative or complementary remedies, including chronic fatigue syndrome, Lyme disease, and HIV/AIDS. Dr.Straus’s career at the National Institutes of Health began in 1979, when he joined NIAID as a senior investigator. Dr. Straus is board certified in internal medicine and infectious diseases. NANCY S. SUNG, Ph.D., is a senior program officer with the Burroughs Wellcome Fund (BWF). She oversees BWF Interfaces in Science Programs, Innovation Awards in Functional Genomics (previous program), and Clinical Scientist Awards in Translational Research. Dr. Sung has also focused on building collaboration among other private foundations, government agencies, and professional societies who share BWF’s interests in strengthening training and career pathways for researchers in the clinical research and physical or computational biology areas. Her research has focused on gene regulation in Epstein-Barr virus and its link to nasopharyngeal carcinoma, which is endemic in southern China. Prior to joining the BWF staff in 1997, Dr. Sung was a visiting fellow at the Chinese Academy of Preventive Medicine’s Institute of Virology in Beijing. NANCY FUGATE WOODS, R.N., Ph.D., is dean of the University of Washington School of Nursing. Dr. Woods is also founding director of the School of Nursing’s internationally known Center for Women’s Health Research and a former chair of the Department of Family and Child Nursing. She was previously the associate dean for research and has been a faculty member at the University of Washington since 1978. Dr. Woods has provided leadership since the 1970s in developing women’s health as a field of study in nursing science. Her early research focused on the relationship between women’s social environments and their health, emphasizing the health consequences of women’s multiple roles and social supports. NELDA WRAY, M.D., is chief research and development officer for the U.S. Department of Veterans Affairs, overseeing the VA research program. Before accepting her current position, Dr. Wray served as chief of general medicine at the Houston VA Medical Center and as professor and chief of health services research at the Baylor College of Medicine in Houston. In 1999 she became the second person to receive the VA Under Secretary Award for Outstanding Achievement in Health Service Research. Dr. Wray is board certified in internal medicine and pulmonary medicine.
OCR for page 94
Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 JOHN YATES, M.D., is president of Takeda Global Research and Development Center Inc. Previously, he served as vice president, Medical and Scientific Affairs (MEDSA) of Merck & Co. Prior to joining MEDSA, Dr.Yates was vice president of clinical development in the U.S. Human Health Division of Merck. He also worked with the then-nascent osteoporosis clinical research team at Merck and subsequently led that team in the development of bisphosphonate alendronate (Fosamax) for treatment and prevention of postmenopausal osteoporosis.
Representative terms from entire chapter: